Exchange Traded Funds Top 10 Volume Leaders
Dow Jones2026/10/02 21:38NET % VOL STOCK (Symbol) LAST CHG CHG 100s
Direxion Semicon Br 3x SOXS 29.71 -2.05 -6.45 100,248,617 ProShares Bitcoin ETF BITO 11.28 -0.05 -0.44 88,992,723 Direxion TSLA Bull 2X TSLL 9.80 0.83 9.25 86,185,861 GrShr 2x Sh NVDA Daily NVD 3.45 -0.09 -2.54 83,994,377 iShares iBoxx $ HY Cp Bd HYG 76.91 0.01 0.01 82,428,971 Leverage 2X Lg TSLA Dly TSLG 4.91 0.42 9.35 75,440,213 SS Utils Sel SPDR XLU 39.83 0.15 0.38 63,631,412 Direxion Semicon Bl 3x SOXL 163.71 10.02 6.52 62,025,577 iSh 20+ Year Treasury Bd TLT 77.48 -0.23 -0.30 61,306,904 ProShares UltraPro QQQ TQQQ 81.01 2.28 2.90 60,640,417
(END) Dow Jones Newswires
October 02, 2026 17:38 ET (21:38 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

BTC market cap briefly dropped out of the top 15 global assets

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit
An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

UNI falls below $5
